(function(){var loadHandler=window['sl_{8824A113-B472-4E24-968F-C628FF6E319A}'];loadHandler&&loadHandler(40, '<div id="spr0_39fbee"><div id="spr1_39fbee" class="kern"><img id="img2_39fbee" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_39fbee"><img id="img0_39fbee" src="data/img0.png" width="960" height="540" alt=""/></div></div><div id="spr2_39fbee" class="kern"><div id="spr4_39fbee" style="left:48px;top:55.5px;"><div style="width:0px;"><span id="txt0_39fbee" class="relpos" style="top:31.634px;">ERCP for acute biliary pancreatitis</span></div></div><div id="spr5_39fbee" style="left:54.756px;top:165.208px;"><div style="width:0px;"><span id="txt1_39fbee" class="nokern relpos" style="left:7.2px;top:7.917px;"></span><span id="txt2_39fbee" class="relpos" style="left:11.852px;top:-0.448px;">potential to cause further damage</span></div><div style="width:0px;"><span id="txt3_39fbee" class="nokern relpos" style="left:7.2px;top:53.997px;"></span><span id="txt4_39fbee" class="relpos" style="left:11.852px;top:45.632px;">prevalence of residual choledocholithiasis in ABP is low (&lt; 30%)</span></div></div><div id="spr6_39fbee" style="left:37.746px;top:298.35px;"><img id="img1_39fbee" src="data/img64.png" width="869" height="71" alt="" style="left:0.188px;"/></div><div id="spr7_39fbee" style="left:571.532px;top:367.352px;"><div style="width:0px;"><span id="txt5_39fbee" class="relpos" style="left:7.2px;top:1.07px;">Gastrointest Endosc 2019;89:1075-105</span></div></div><div id="spr8_39fbee" style="left:338.252px;top:445.768px;"><div style="width:0px;"><span id="txt6_39fbee" class="relpos" style="left:7.2px;top:-0.448px;">EUS before ERCP?</span></div></div></div></div>');})();